Skip to content
The Policy VaultThe Policy Vault

ibrexafungerpCareFirst (Caremark)

Vulvovaginal Candidiasis (VVC)

Preferred products

  • fluconazole

Initial criteria

  • The requested drug is being prescribed for an adult or post‑menarchal pediatric patient.
  • The patient has experienced an inadequate treatment response to a course of therapy with fluconazole OR the patient has experienced an intolerance to fluconazole OR the patient has a contraindication that would prohibit a trial of fluconazole.
  • The requested drug is NOT being used in a footbath.

Approval duration

7 days